Project Details
Description
International, Randomized, Open-Label, Phase 3 Trial of Gemcitabine/Cisplatin Versus Gemcitabine/Cisplatin Alone as First-Line Treatment of Patients with Advanced
Status | Finished |
---|---|
Effective start/end date | 1/3/06 → 12/31/10 |
Funding
- PFIZER, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.